Sheaff Brock Investment Advisors, LLC Bio Affinity Technologies, Inc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.58 Billion
- Q1 2024
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 10,000 shares of BIAF stock, worth $21,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$21,600% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
240KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA70.3KShares$151,9040.0% of portfolio
-
Geode Capital Management, LLC Boston, MA42.1KShares$90,8880.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny37.5KShares$81,0000.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$60,2310.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$38,0160.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $5.89M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...